Comment on: Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence.

Rheumatology (Oxford, England)

Volumn 48, Issue 10, 2009, Pages

  Chikura, Batsi ^a   Sadananda, Veena ^a   Usman Saeed, Muniba ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR ALPHA;

DRUG ANTAGONISM; HUMAN; MEDICAL AUDIT; NOTE; PRACTICE GUIDELINE; TUBERCULOSIS; UNITED KINGDOM;

GREAT BRITAIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MEDICAL AUDIT; PRACTICE GUIDELINES AS TOPIC; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350757742     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep181     Document Type: Note

References (0)